Melasma in people with darker skin types : a scoping review protocol on prevalence, treatment options for melasma and impact on quality of life

Show simple item record

dc.contributor.author Mpofana, Nomakhosi
dc.contributor.author Chibi, Buyisile
dc.contributor.author Gqaleni, Nceba
dc.contributor.author Hussein, Ahmed
dc.contributor.author Finlayson, Avenal Jane
dc.contributor.author Kgarosi, Kabelo
dc.contributor.author Dlova, Ncoza Cordelia
dc.date.accessioned 2024-01-16T08:34:42Z
dc.date.available 2024-01-16T08:34:42Z
dc.date.issued 2023-08-10
dc.description ADDITIONAL FILE 1. PRISMA ScR. en_US
dc.description AVAILABILITY OF DATA AND MATERIALS : All data generated or analysed during this study will be included in the published scoping review article and will be available upon request. en_US
dc.description.abstract BACKGROUND : Melasma is one of the most encountered dermatoses in dermatology and skin care clinics. It is a challenging chronic, recurrent condition associated with hyperpigmentation. Its aetiology is poorly understood. Melasma affects all races and gender but is more prevalent in women with darker skin types. Being a facial lesion, melasma has a severe impact on quality of life due to its disfigurement. While many modalities of treatment for melasma exists, unfortunately, effectiveness and safety remain a huge concern. Treatment modalities are variable and often unsatisfactory. The objective of this scoping review is to systemically map available evidence from literature regarding melasma on people with darker skin types, garner insight as to how melasma affects the quality of life and begin to investigate and gain understanding on effectiveness of different treatments used for melasma. METHODS : A scoping review guided by Arksey and O’Malley’s framework, the enhancements and recommendations of Levac, Colquhoun and O’Brien, Daudt and associates and the 2015 Johanna Briggs Institute’s guidelines will be conducted. Systematic electronic searches of databases and search engines will include Scopus, PubMed, CINAHL Complete, Cochrane, Science Direct, and Web of Science which will be conducted to attain published peer reviewed articles of all study designs excluding reviews and grey literature. All literature that meets the inclusion criteria, research question and sub-question will be included in this review. All the retrieved literature will be exported to an Endnote X20 library. Quality appraisal of the included articles will be conducted using the mixed methods appraisal tool (MMAT) 2018 version. DISCUSSION : We anticipate mapping relevant literature on the melasma, investigating the effectiveness of treatment options of melasma as well as evaluating its association with quality of life in people with darker skin types. This study is likely to reveal research gaps, which could guide future implementation research on melasma treatment interventions. SYSTEMATIC REVIEW REGISTRATION : This protocol has been registered a priori with OSF and is accessible on this link: https:// osf. io/ ru3jc/. en_US
dc.description.department Department of Library Services en_US
dc.description.librarian am2024 en_US
dc.description.sdg SDG-03:Good heatlh and well-being en_US
dc.description.sponsorship The Durban University of Technology Seed Funding grant and funding from UNICEF and with support from Future Africa, the University of Pretoria. en_US
dc.description.uri https://systematicreviewsjournal.biomedcentral.com/ en_US
dc.identifier.citation Mpofana, N., Chibi, B., Gqaleni, N. et al. 2023, 'Melasma in people with darker skin types : a scoping review protocol on prevalence, treatment options for melasma and impact on quality of life', Systematic Reviews, vol. 12, art. 139, pp. 1-8. https://DOI.org/10.1186/s13643-023-02300-7. en_US
dc.identifier.issn 2046-4053 (online)
dc.identifier.other 10.1186/s13643-023-02300-7
dc.identifier.uri http://hdl.handle.net/2263/93980
dc.language.iso en en_US
dc.publisher BMC en_US
dc.rights © The Author(s) 2023. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License. en_US
dc.subject Melasma en_US
dc.subject Chloasma en_US
dc.subject Hyperpigmentation en_US
dc.subject Hypermelanosis en_US
dc.subject Treatment en_US
dc.subject Therapy en_US
dc.subject SDG-03: Good health and well-being en_US
dc.title Melasma in people with darker skin types : a scoping review protocol on prevalence, treatment options for melasma and impact on quality of life en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record